Stockreport

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]

Whitehawk Therapeutics, Inc.  (WHWK) 
PDF advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced it will present three [Read more]